Ligand Pharmaceuticals | LGND - Fremdkapital





Fremdkapital Veränderung Datum
Agenus USD 153.98M 15.68M 2026-03
Amgen USD 51.86B 27M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
Baxter International USD 8.62B 6M 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Enanta Pharmaceuticals USD 0 0 2024-12
Enviri Corporation USD 1.56B 26.44M 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Glaxosmithkline GBP 18.53B 1.29B 2026-03
Heron Therapeutics USD 140.64M 975K 2025-12
Insmed USD 543.51M 1.3M 2026-06
Intrexon USD 0 198.67M 2024-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Ligand Pharmaceuticals USD 446.9M 704K 2026-03
MacroGenics USD 68.71M 1.29M 2026-03
Merck USD 51.08B 4.41B 2026-06
Pacira USD 363.12M 4.53M 2026-06
Pfizer USD 60.5B 70M 2026-06
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 0 0 2025-03